midodrine has been researched along with Weight Loss in 1 studies
Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.
Weight Loss: Decrease in existing BODY WEIGHT.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of the present work was to study the role of midodrine in patients with non-azotemic cirrhosis with tense ascites." | 9.19 | Clinical study on the therapeutic role of midodrine in non azotemic cirrhotic patients with tense ascites: a double-blind, placebo-controlled, randomized trial. ( Al-Garem, N; Ali, A; Amin, M; Farid, S; Kassem, M, 2014) |
| "The objective of the present work was to study the role of midodrine in patients with non-azotemic cirrhosis with tense ascites." | 5.19 | Clinical study on the therapeutic role of midodrine in non azotemic cirrhotic patients with tense ascites: a double-blind, placebo-controlled, randomized trial. ( Al-Garem, N; Ali, A; Amin, M; Farid, S; Kassem, M, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, A | 1 |
| Farid, S | 1 |
| Amin, M | 1 |
| Kassem, M | 1 |
| Al-Garem, N | 1 |
1 trial available for midodrine and Weight Loss
| Article | Year |
|---|---|
Clinical study on the therapeutic role of midodrine in non azotemic cirrhotic patients with tense ascites: a double-blind, placebo-controlled, randomized trial.
Topics: Adrenergic alpha-1 Receptor Agonists; Aged; Ascites; Blood Flow Velocity; Double-Blind Method; Drain | 2014 |